PharmaShots | Incisive News in 3 Shots

Subscribe Now

Vasomotor Symptoms

Bayer Initiates P-III OASIS Program of Elinzanetant for the Treatment of Vasomotor Symptoms During Menopause

Bayer Initiates P-III OASIS Program of Elinzanetant for the Treatment of Vasomotor Symptoms During Menopause

September 1, 2021

Bayer to Acquire KaNDy Therapeutics for Augmenting its Women's Healthcare Portfolio

Bayer to Acquire KaNDy Therapeutics for Augmenting its Women's Healthcare Portfolio

August 11, 2020

Astellas Initiates P-III BRIGHT SKY Clinical Program for Fezolinetant in Postmenopausal Women with Vasomotor Symptoms

Astellas Initiates P-III BRIGHT SKY Clinical Program for Fezolinetant in Postmenopausal Women with Vasomotor Symptoms

August 6, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us